2.5 mg tirzepatide in syringe Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity TIZARO 2.5MG at ₹ 6600/vial

Bc s c th cn iu chnh liu hoc theo di cht ch khi phi hp thuc

Treatment decisions when prescribing SGLT2is and/or GLP-1 RAs in adults with CKD and T2D who have overweight/obesity are strongly influenced by tolerability and safety (88%)

Patients and their advocates have frequently criticized RECOVER leaders decision to prioritize nondrug treatments like videogames and exercise therapy during the first phase of RECOVER-TLCa tension that colored discussions during this weeks meeting

References Kim W, Egan JM

16 This is especially seen in assisted reproductive settings used due to infertility problems stemming from advanced age and poor ovarian reserve, where it can play a role in mitigating metabolic and reproductive disturbances and enhancing the odds of pregnancy post-IVF

This mechanism is physiologically important as hepatocytes supply GSH found in the plasma, which is used as a source of cysteine for GSH synthesis in other cells (Anderson et al., 1980)